Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells

doi:10.3748/wjg.v26.i48.7593

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7330)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

438

WORD

209

HTML

3633

Figures (1-1)

533

Sum=4813

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

284

Download

491

Sum=775

Publishing Process of This Article

Item

Count

Browse

717

Download

1025

Sum=1742

Dec 28, 2020 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Dec 28, 2020; 26(48): 7593-7602
Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7593

Open in New Tab Full Size Figure Download Figure

Figure 1 Underlying mechanisms of vasoactive intestinal peptide interference of ulcerative colitis by regulating the expression of interleukin-10 in regulatory B cells. Breg: Regulatory B cell; IL: Interleukin; Th: T helper; TNF-α: Tumor necrosis factor-α; UC: Ulcerative colitis; VIP: Vasoactive intestinal peptide.

Citation: Sun X, Huang Y, Zhang YL, Qiao D, Dai YC. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World J Gastroenterol 2020; 26(48): 7593-7602
URL: https://www.wjgnet.com/1007-9327/full/v26/i48/7593.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i48.7593